Evaluation of the Reproductive Toxicity and Embryotoxicity of Insulin Glargine (LANTUS) in Rats and Rabbits
Abstract
Insulin glargine (LANTUS) is a new insulin analog that has a prolonged duration of action with no pronounced peak of activity, rendering it an ideal basal insulin for the treatment of diabetes. The aim of these studies was to assess the reproductive and embryotoxicity of insulin glargine. Reproductive toxicity was assessed in 25 male and 25 female Wistar rats per group treated with a daily subcutaneous injection of control; 1 IU/kg, 3 IU/kg, and 10 IU/kg insulin glargine; or 3 IU/kg NPH insulin in the premating and mating periods, and throughout pregnancy and lactation in the females. Embryotoxicity was assessed in 20 female rats per group injected with daily subcutaneous doses of control; 2 IU/kg, 6.3 IU/kg, and 20 IU/kg insulin glargine; or 6.3 IU/kg NPH insulin from the 7th to 18th day of pregnancy. Embryotoxicity was also assessed in 20 female rabbits per group treated with 0 IU/kg, 0.5 IU/kg, 1 IU/kg, and 2 IU/kg insulin glargine, or 1 IU/kg NPH insulin from the 6th to 18th day of pregnancy. The data demonstrated that, with the exception of toxicologic effects induced by hypoglycemia in response to high doses of insulin glargine and NPH insulin (including the premature dropout of female rats in the reproductive toxicity study, and increased incidence of abortions, early intrauterine deaths, and single anomalies in the rabbit embryotoxicity study), insulin glargine had no effects on reproduction, embryofetal development, and postnatal development in rats. Maternal and embryofetal toxicity in rabbits treated with middle and high doses of insulin glargine was related to the hypoglycemic effect of insulin.
References
Baeder, C. 1993. Embryotoxicological/teratological investigation, including effects on postnatal development, of the new oral antidiabetic glimepiride after oral administration to rats and rabbits. Clin. Rep. 27:45–60.
Brinsmade, A., F. Buchner, and H. Rubsamen. 1956. Missbildungen am Kaninchenembryo durch Insulininjektion beim Muttertier. Naturwiss 43:259.
Chomette, G. 1955. Entwicklungsstörungen nach Insulinschoc k beim trächtigen Kaninchen. Beitr. Pathol. Anat. 115:439–451.
Ciofetta, M., C. Lalli, P. D. Sindaco, E. Torlone, S. Pampanelli, L. Mauro, D. L. Chiara, P. Brunetti, and G. B. Bolli. 1999. Contribution of postprandial versus interprandial blood glucose to Hb A1C in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. Diabetes Care 22:795–800.
Hannah, S., and L. Moore. 1971. Effects of fasting and insulin on skeletal development in rats. Teratology 4:135–140.
Heinemann, L., R. Linkeschowa, K. Rave, B. Hompesch, M. Sedalk, and T. Heise. 2000. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 23:644–649.
Home, P. 1999. Insulin glargine: The first clinically useful extended-acting insulin in half a century? Expert Opin. Investig. Drugs 8:307–314.
Miyamoto, M., T. Sakaguchi, and O. Midorikawa. 1977. Teratogenic effect of sulfonylureas and insulin in rats. Cong. Anom. 17:31–37.
Scaglione, S. 1962. Osservazionee ricerche sull’ azione dell 'insulina sugli embrioni di ratte gravide con microfotografie. Acta Genet. Med. 11:418–429.
Stammberger, I., A. Bube, B. Durchfeld-Meyer, H. Donaubauer, and G. Troschau. 2002. Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mice. Int. J. Toxicol. 21:171–179.
Tanigawa, K., M. Kawaguchi, O. Tanaka, and Y. Kato. 1991. Skeletal malformations in rat offspring. Long-term effect of maternal insulin-induced hypoglycemia during organogenesis. Diabetes 40:1115–1121.
Vajo, Z., and W. Duckworth. 2000. Genetically engineered insulin analogs: Diabetes in the new millennium. Pharmacol. Rev. 52:1–9.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published: May 2002
Issue published: May 2002
Keywords
PubMed: 12055019
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in International Journal of Toxicology.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 377
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 58 view articles Opens in new tab
Crossref: 0
-
Evolving toxicological measurements for pharmaceutical waste-induced h...
-
Disruption of fetal eye development caused by insulin-induced maternal...
-
Effects of glucokinase activator, DS-7309, on embryo-fetal development...
-
Insulin Crystals Grown in Short-Peptide Supramolecular Hydrogels Show ...
-
Use of insulin glargine during pregnancy: A review
-
Importance of gestational hypoglycaemia for foetal malformations and s...
-
Applying a weight of evidence approach to the evaluation of developmen...
-
Rethinking developmental toxicity testing: Evolution or revolution?
-
High-Risk Pregnancy
-
Effects of maternal hypoglycemia on fetal eye and skeleton development...
-
Safety of insulin analogues as compared with human insulin in pregnanc...
-
Perspective on a Modified Developmental and Reproductive Toxicity Test...
-
Management of diabetes and pregnancy – When to start and what pharmaco...
-
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideli...
-
The use of insulin analogues in pregnancy
-
Management of pregnancy in women with type 1 diabetes mellitus: Guidel...
-
Basal insulin analogues in diabetic pregnancy: a literature review and...
-
Insulin Glargine Use During Pregnancy
-
Prise en charge de la grossesse au cours du diabète de type 1
-
Prise en charge de la grossesse au cours du diabète de type 1
-
Placental Transfer of the Insulin Analog Glargine in the Ex Vivo Perfu...
-
Therapeutic management of gestational diabetes
-
Pregnancy in Women with Complicated Diabetes Mellitus
-
Glargine vs. NPH insulin therapy in pregnancies complicated by diabete...
-
Use of insulin glargine throughout pregnancy in 102 women with type 1 ...
-
Reproductive Toxicity Testing for Biopharmaceuticals
-
Insulin glargine reduces carotid intimal hyperplasia after balloon cat...
-
Considerations in assessing the developmental and reproductive toxicit...
-
Insulin glargine compared with Neutral Protamine Hagedorn insulin in t...
-
Type 2 diabetes in pregnancy: importance of optimized care before, dur...
-
Gestational diabetes: diagnosis and management
-
Insulin glargine and its role in glycaemic management of Type 2 diabet...
-
Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-m...
-
Survey of glargine use in 115 pregnant women with Type 1 diabetes
-
Treating the mother – protecting the unborn: The safety of hypoglycemi...
-
Current management of gestational diabetes mellitus
-
Glargine in pregnant patients with Type 1 diabetes
-
Archivée: Tératogénicité associée aux diabètes gestationnel et préexis...
-
RETIRED: Teratogenicity Associated With Pre-Existing and Gestational D...
-
The use of glargine in pregnancy
-
Insulin Analogues in the Treatment of Diabetes in Pregnancy
-
Insulin Analogs and Pregnancy
-
Use of insulin glargine during pregnancy: a case–control pilot study
-
Novel insulin analogues and its mitogenic potential
-
The insulin analog glargine during an unplanned pregnancy
-
Insulin glargine and its place in the treatment of Types 1 and 2 diabe...
-
Safety and side effects of the insulin analogues
-
Use of Insulin Glargine During Pregnancy in Seven Type 1 Diabetic Wome...
-
Insulin therapy in pregnancy complicated by diabetes: are insulin anal...
-
Use of Insulin Glargine During the First Weeks of Pregnancy in Five Ty...
-
Uso de insulina glargina en el período preconcepcional
-
Teratogenicity with angiotensin II receptor antagonists in pregnancy
-
A Critical Appraisal of the Role of Insulin Analogues in the Managemen...
-
Diabetes mellitus in pregnancy
-
Use of insulin glargine during embryogenesis in a pregnant woman with ...
-
Insulin glargine: A systematic review of a long-acting insulin analogu...
-
Diabetes in Pregnancy
Figures and tables
Figures & Media
Tables
View Options
View options
PDF/ePub
View PDF/ePubGet access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
ACT members can access this journal content using society membership credentials.
ACT members can access this journal content using society membership credentials.
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
